Litcius/Paper detail

Targeted Molecular Construct for Bioorthogonal Theranostics of PD-L1-Expressing Cancer Cells

Shiao Y. Chow, Asier Unciti‐Broceta

2022JACS Au16 citationsDOIOpen Access PDF

Abstract

by click-to-release activation of prodrugs and selective killing of PD-L1-expressing breast cancer cells, offering a new multimodal approach to "track-&-treat" malignant cells that are capable of evading the immune system.

Topics & Concepts

Bioorthogonal chemistryCancer cellChemistryClick chemistryTetrazineCancer researchLigand (biochemistry)ConjugateCancerBiochemistryBiologyCombinatorial chemistryReceptorMathematical analysisOrganic chemistryGeneticsMathematicsClick Chemistry and ApplicationsCAR-T cell therapy researchMonoclonal and Polyclonal Antibodies Research
Targeted Molecular Construct for Bioorthogonal Theranostics of PD-L1-Expressing Cancer Cells | Litcius